Close Menu

NEW YORK – Waters reported before the opening of the market on Tuesday that its second quarter revenues were flat year over year, though the company noted that it expects new product introductions and improving end markets will drive growth in the second half of 2019.

For the three months ended June 29, the company posted Q2 revenues of $599.2 million, up less than 1 percent from $596.2 million in Q2 2018, and short of the average Wall Street estimate of $601.4 million. Foreign currency translation depressed revenues by 2 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.